Fig. 1: Outcome and efficacy of drugs in hospitalized patients with COVID-19. | Cell Discovery

Fig. 1: Outcome and efficacy of drugs in hospitalized patients with COVID-19.

From: Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs

Fig. 1

a Outcome (28/30-day mortality) and efficacy of telmisartan, losartan, and 11 drugs recommended by China, FDA, EMA and WHO. b Outcome (21/28/30-day mortality) and efficacy of drugs in hospitalized patients admitted to ICU. c Outcome (28/30-day mortality) and efficacy of drugs in hospitalized patients undergoing invasive mechanical ventilation. d Outcome (28/30-day mortality) and efficacy of drugs in hospitalized patients receiving oxygen only. e Outcome (14/15-day mortality) and efficacy of drugs in hospitalized patients. f Outcome (21-day mortality) and efficacy of drugs in hospitalized patients.

Back to article page